---
title: "Weekly Recap | Travellers -0.15%, most brokers rate it hold"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299514973.md"
description: "Travellers (TRV) finished the week down 0.15% at $374.62, underperforming the S&P 500 by roughly 0.07 percentage points. It was a choppy stretch: Monday opened at $383 and closed near $378.05, Tuesday and Wednesday held a narrow band around $377 to $379, Thursday touched an intraday high of $382.97, and Friday slid to $372.53 before settling at $374.62. Weekly amplitude came to about 2.99%, with average daily volume of 1.74m shares running 9.79% above the prior median."
datetime: "2026-09-19T06:52:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299514973.md)
  - [en](https://longbridge.com/en/news/299514973.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299514973.md)
generator: "portal-rs"
---

# Weekly Recap | Travellers -0.15%, most brokers rate it hold

## The Week

Travellers (TRV) finished the week down 0.15% at $374.62, underperforming the S&P 500 by roughly 0.07 percentage points. It was a choppy stretch: Monday opened at $383 and closed near $378.05, Tuesday and Wednesday held a narrow band around $377 to $379, Thursday touched an intraday high of $382.97, and Friday slid to $372.53 before settling at $374.62. Weekly amplitude came to about 2.99%, with average daily volume of 1.74m shares running 9.79% above the prior median.

## Key Events

The week’s headlines centred on valuation talk and position updates. On 14 September, Corient Private Wealth LP disclosed an increase in its TRV stake, and a separate note suggested the stock could sit about 6% above fair value after its sharp run. On 16 September, Mizuho Securities reaffirmed its hold rating on the name. There were no company-level product, earnings or regulatory announcements during the week.

## Analyst Ratings

Across 29 institutions covering Travellers, 5 rate it buy, 1 overweight, 17 hold, 2 underweight and 4 sell. The consensus rating is hold, with a consensus target of $360.54, implying roughly -3.76% versus the spot price of $374.62. Targets range from $262 to $430, pointing to a wide spread of views. Within the property and casualty insurance industry, Travellers ranks 1st out of 59 names.

## The Week Ahead

US macro data dominates the early part of next week: the Richmond Fed manufacturing index on 22 September, EIA weekly crude and Cushing inventories on 23 September, then jobless claims, current account balance, new home sales and EIA natural gas storage on 24 September. Travellers will report fiscal Q3 2026 results before the open on 16 October, with consensus estimates near $6.86 in EPS and about $11bn in revenue.

## In Short

The week offered little directional force: Travellers edged lower and lagged the market, while the analyst base skewed neutral and the consensus target sat slightly below spot. At around 9.48x P/E and 2.36x P/B, valuation remains modest, and the name still tops its industry in rating rank. The next focal points are the Q3 report on 16 October and the macro calendar through the coming week.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [TRV.US](https://longbridge.com/en/quote/TRV.US.md)

## Related News & Research

- [Travelers Companies (TRV) Could Be 6% Above Fair Value After Its Sharp Run](https://longbridge.com/en/news/298887540.md)
- [Corient Private Wealth LP Increases Stock Holdings in The Travelers Companies, Inc. $TRV](https://longbridge.com/en/news/298881850.md)
- [VIRGINIA RETIREMENT SYSTEMS ET Al Purchases Shares of 160,700 The Travelers Companies, Inc. $TRV](https://longbridge.com/en/news/298199815.md)
- [Michael Saylor Says, 'A Little More Orange': Will Strategy Report BTC Purchases After Hitting Pause for 3 Weeks?](https://longbridge.com/en/news/299601303.md)
- [Travelers earnings beat estimates. Does it prove recent downgrades wrong?](https://longbridge.com/en/news/293034941.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**